Company: SNY
Filing Date: 2025-03-27
Form Type: S-8
Source: 0001193125-25-065210
Chunk: 2

Company: Sanofi
Filing Date: 2025-03-27
Form: S-8
Chunk 2
---
 Corporate & Finance at the Registrant, has given her opinion about certain legal matters affecting the securities registered under this Registration Statement. Ms. Roger owns, or may have the right to acquire, the Registrant’s Ordinary Shares and/or American Depository Shares. Item 6. Indemnification of Directors and Officers. The French Commercial Code prohibits provisions of corporate articles of associations that limit the liability of directors. However, if a director is sued by a third party and ultimately prevails in the litigation on all counts but is nevertheless required to bear attorneys’ fees and costs, the director may be reimbursed for those fees and costs pursuant to an indemnification arrangement.

Under French law a company may purchase directors and officers insurance for all or part of the members of its management. A French corporation is responsible to third parties for the consequences of the decisions of its board of directors. However, if those decisions qualify as mismanagement, the relevant member of the board of directors may have to fully or partly indemnify the company. Sanofi has purchased insurance for all of its directors and officers. Item 7. Exemption from Registration Claimed. Not applicable. Item 8. Exhibits. See Exhibit Index. Item 9. Undertakings. The undersigned Registrant hereby undertakes:

| (1) | To file, during any period in which offers or sales are being made, a post-effective amendment to this 
 Registration Statement:                                                                                |

| (i) | To include any prospectus required by Section 10(a)(3) of the Securities Act; |

| (ii) | To reflect in the prospectus any facts or events arising after the effective date of the Registration Statement                                                                                
 (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this Registration Statement; and |

| (iii) | To include any material information with respect to the plan of distribution not previously disclosed in the 
 registration statement or any material change to such information in the Registration Statement;             |

provided, however, that paragraphs (i) and (ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or 15(d) of the Exchange Act that are incorporated by reference in the Registration Statement;

| (2) | That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment